• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有和未患有多发性硬化症女性的活产率、不孕症诊断及不孕症治疗:来自行政索赔数据库的数据

Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database.

作者信息

Houtchens Maria K, Edwards Natalie C, Hayward Brooke, Mahony Mary C, Phillips Amy L

机构信息

Brigham and Women's Hospital, Harvard Medical School, Brookline, MA, USA.

Health Services Consulting Corporation, Boxborough, MA, USA.

出版信息

Mult Scler Relat Disord. 2020 Nov;46:102541. doi: 10.1016/j.msard.2020.102541. Epub 2020 Sep 28.

DOI:10.1016/j.msard.2020.102541
PMID:33296964
Abstract

BACKGROUND

Real-world data regarding live birth rates (LBRs) and infertility in women with multiple sclerosis (MS) are lacking. This study compared LBRs, infertility diagnoses, and infertility treatments in women with and without MS.

METHODS

Using a retrospective US administrative claims database, patients 18-55 years with MS were matched 1:1 to patients without MS to compare LBRs, infertility diagnoses, and infertility treatments used between cohorts.

RESULTS

Overall LBRs were lower in women with MS (n=96,937) versus women without (n=96,937; 5.0% vs 7.0%; p<0.0001). A greater proportion of women with MS than without had a diagnosis of infertility (8.5% vs 8.1%; p=0.0006). Fewer women with MS than without used any infertility treatment (1.0% vs 1.2%; p=0.0002). Among women with or without MS who received infertility treatments, no significant difference was observed in LBRs with oral (32.2% vs 31.5%; p=0.8536) or injectable (44.0% vs 49.3%; p=0.2603) treatment.

CONCLUSION

Women with MS had a lower LBR, received more infertility diagnoses, and were less likely to receive infertility treatment than women without MS. There was no difference in LBRs following infertility treatment. Claims-data studies provide valuable exploratory analyses that reflect interactions between patients and the healthcare system.

摘要

背景

关于多发性硬化症(MS)女性的活产率(LBRs)和不孕症的真实世界数据尚缺。本研究比较了患有和未患有MS的女性的LBRs、不孕症诊断和不孕症治疗情况。

方法

利用美国一个回顾性行政索赔数据库,将18 - 55岁的MS患者与未患MS的患者按1:1配对,以比较两组之间的LBRs、不孕症诊断和所使用的不孕症治疗方法。

结果

患有MS的女性(n = 96,937)的总体LBRs低于未患MS的女性(n = 96,937;5.0%对7.0%;p < 0.0001)。与未患MS的女性相比,患有MS的女性中诊断为不孕症的比例更高(8.5%对8.1%;p = 0.0006)。接受任何不孕症治疗的患有MS的女性比未患MS的女性更少(1.0%对1.2%;p = 0.0002)。在接受不孕症治疗的患有或未患有MS的女性中,口服治疗(32.2%对31.5%;p = 0.8536)或注射治疗(44.0%对49.3%;p = 0.2603)后的LBRs无显著差异。

结论

与未患MS的女性相比,患有MS的女性LBRs较低,接受不孕症诊断的更多,且接受不孕症治疗的可能性更小。不孕症治疗后的LBRs没有差异。索赔数据研究提供了有价值的探索性分析,反映了患者与医疗保健系统之间的相互作用。

相似文献

1
Live birth rates, infertility diagnosis, and infertility treatment in women with and without multiple sclerosis: Data from an administrative claims database.患有和未患有多发性硬化症女性的活产率、不孕症诊断及不孕症治疗:来自行政索赔数据库的数据
Mult Scler Relat Disord. 2020 Nov;46:102541. doi: 10.1016/j.msard.2020.102541. Epub 2020 Sep 28.
2
Pregnancy rates and outcomes in women with and without MS in the United States.美国有和无多发性硬化症的女性的妊娠率和结局。
Neurology. 2018 Oct 23;91(17):e1559-e1569. doi: 10.1212/WNL.0000000000006384. Epub 2018 Sep 28.
3
Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs.基于索赔数据的指标用于评估接受疾病修正药物治疗的多发性硬化症患者疾病状态的开发与验证
BMC Neurol. 2017 Jun 5;17(1):106. doi: 10.1186/s12883-017-0887-1.
4
Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis.用于治疗多发性硬化症的芬戈莫德与那他珠单抗的医疗资源使用及复发情况:一项美国索赔数据库回顾性分析
Curr Med Res Opin. 2014 Aug;30(8):1461-71. doi: 10.1185/03007995.2014.915802. Epub 2014 May 2.
5
Cumulative live birth rates for women returning to ART treatment for a second ART-conceived child.女性因第二个接受 ART 受孕的孩子而返回接受 ART 治疗的累积活产率。
Hum Reprod. 2020 Jun 1;35(6):1432-1440. doi: 10.1093/humrep/deaa030.
6
Cost-effectiveness analysis of lifestyle intervention in obese infertile women.生活方式干预对肥胖不孕妇女的成本效益分析。
Hum Reprod. 2017 Jul 1;32(7):1418-1426. doi: 10.1093/humrep/dex092.
7
Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS.美国多发性硬化症女性患者在妊娠和活产期间的复发和疾病修饰药物治疗。
Neurology. 2018 Oct 23;91(17):e1570-e1578. doi: 10.1212/WNL.0000000000006382. Epub 2018 Sep 28.
8
Elective single blastocyst transfer in advanced maternal age.高龄产妇的选择性单囊胚移植
J Assist Reprod Genet. 2017 Jun;34(6):741-748. doi: 10.1007/s10815-017-0906-6. Epub 2017 Mar 15.
9
Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.1050名女性在一个辅助生殖技术周期(包括所有后续冻融周期)后的累积活产率:一项比较促性腺激素释放激素拮抗剂和促性腺激素释放激素激动剂方案的随机对照试验的次要结果。
Hum Reprod. 2017 Mar 1;32(3):556-567. doi: 10.1093/humrep/dew358.
10
Novel use of COMET parameters of sperm DNA damage may increase its utility to diagnose male infertility and predict live births following both IVF and ICSI.精子 DNA 损伤的彗星参数的新用途可能会提高其用于诊断男性不育症的效用,并可预测体外受精和卵胞浆内单精子注射后的活产率。
Hum Reprod. 2019 Oct 2;34(10):1915-1923. doi: 10.1093/humrep/dez151.

引用本文的文献

1
Strategies in Tissue Regenerative Engineering for the Treatment of Human Infertility.用于治疗人类不孕症的组织再生工程策略。
Stem Cell Rev Rep. 2025 Sep 4. doi: 10.1007/s12015-025-10964-y.
2
Disease-modifying therapy during pregnancy and postpartum relapse activity in women with multiple sclerosis undergoing assisted reproductive technology treatment: a nationwide cohort study.多发性硬化症女性在接受辅助生殖技术治疗期间的疾病修饰治疗及产后复发活动:一项全国性队列研究。
BMJ Neurol Open. 2025 Jul 3;7(2):e001092. doi: 10.1136/bmjno-2025-001092. eCollection 2025.
3
Multiple sclerosis, urinary tract infections and infertility: a comprehensive scoping review.
多发性硬化症、尿路感染与不孕症:一项全面的范围综述
J Turk Ger Gynecol Assoc. 2025 Jun 10;26(2):130-141. doi: 10.4274/jtgga.galenos.2024.2024-5-2.
4
Reduced childbirth rates in multiple sclerosis from the prodromal phase: Evidence from a population-based cohort study.多发性硬化症前驱期分娩率降低:基于人群队列研究的证据。
Mult Scler. 2025 Apr;31(4):398-407. doi: 10.1177/13524585251315077. Epub 2025 Feb 17.
5
Evaluation of ovarian reserve and the assisted reproductive technology (ART) cycles' outcome as well as the relapse rate within one year after ART in women with multiple sclerosis: a case-control study.评估卵巢储备功能以及辅助生殖技术 (ART) 周期的结局,以及多发性硬化症女性在 ART 后一年内的复发率:一项病例对照研究。
J Ovarian Res. 2024 Aug 13;17(1):165. doi: 10.1186/s13048-024-01483-4.
6
Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis: Dispelling the Myths.多发性硬化症患者孕期管理的实际考量:破除误解
Neurol Clin Pract. 2024 Apr;14(2):e200253. doi: 10.1212/CPJ.0000000000200253. Epub 2024 Feb 13.
7
Male sexual and reproductive health in multiple sclerosis: a scoping review.多发性硬化症中的男性性与生殖健康:一项范围综述
J Neurol. 2024 May;271(5):2169-2181. doi: 10.1007/s00415-024-12250-2. Epub 2024 Feb 28.
8
Optimizing the "Time to pregnancy" in women with multiple sclerosis: the OPTIMUS Delphi survey.优化多发性硬化症女性的“受孕时间”:OPTIMUS德尔菲调查
Front Neurol. 2023 Oct 6;14:1255496. doi: 10.3389/fneur.2023.1255496. eCollection 2023.
9
Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis.患有多发性硬化症的不孕女性的辅助生殖技术与疾病管理
CNS Drugs. 2023 Oct;37(10):849-866. doi: 10.1007/s40263-023-01036-1. Epub 2023 Sep 7.
10
Inflammatory Activity After Diverse Fertility Treatments: A Multicenter Analysis in the Modern Multiple Sclerosis Treatment Era.不同生育治疗后的炎症活动:现代多发性硬化治疗时代的多中心分析。
Neurol Neuroimmunol Neuroinflamm. 2023 Mar 15;10(3). doi: 10.1212/NXI.0000000000200106. Print 2023 May.